Laboratory of Experimental Therapeutics, Department of Clinical Medicine, School of Medicine, University of Sao Paulo, Sao Paulo, SP, Brazil.
Laboratory of Studies in Pulmonary Inflammation, Department of Bioscience, Federal University of Sao Paulo, Diadema, SP, Brazil.
Sci Rep. 2020 Sep 17;10(1):15287. doi: 10.1038/s41598-020-72305-y.
Th17/Treg imbalance contributes to chronic obstructive pulmonary disease (COPD) development and progression. However, intracellular signaling by suppressor of cytokine signaling (SOCS) 1 and SOCS3 and the proteins signal transducer and activator of transcription (STAT) 3 and STAT5 that orchestrate these imbalances are currently poorly understood. Thus, these proteins were investigated in C57BL/6 mice after exposure to cigarette smoke (CS) for 3 and 6 months. The expression of interleukin was measured by ELISA and the density of positive cells in peribronchovascular areas was quantified by immunohistochemistry. We showed that exposure to CS in the 3rd month first induced decreases in the numbers of STAT5+ and pSTAT5+ cells and the expression levels of TGF-β and IL-10. The increases in the numbers of STAT3+ and pSTAT3+ cells and IL-17 expression occurred later (6th month). These findings corroborate the increases in the number of SOCS1+ cells in both the 3rd and 6th months, with concomitant decreases in SOCS3+ cells at the same time points. Our results demonstrated that beginning with the initiation of COPD development, there was a downregulation of the anti-inflammatory response mediated by SOCS and STAT proteins. These results highlight the importance of intracellular signaling in Th17/Treg imbalance and the identification of possible targets for future therapeutic approaches.
Th17/Treg 失衡导致慢性阻塞性肺疾病(COPD)的发生和发展。然而,细胞内信号转导抑制细胞因子信号(SOCS)1 和 SOCS3 以及信号转导和转录激活因子(STAT)3 和 STAT5 的蛋白,协调这些失衡目前了解甚少。因此,在 C57BL/6 小鼠暴露于香烟烟雾(CS)3 个月和 6 个月后,研究了这些蛋白。通过 ELISA 测量白细胞介素的表达,并用免疫组织化学定量测量支气管血管周围区域阳性细胞的密度。结果表明,CS 暴露在第 3 个月首先诱导 STAT5+和 pSTAT5+细胞数量以及 TGF-β和 IL-10 的表达水平降低。STAT3+和 pSTAT3+细胞数量和 IL-17 表达的增加发生在稍后(第 6 个月)。这些发现证实了在第 3 个月和第 6 个月 SOCS1+细胞数量增加,同时在相同时间点 SOCS3+细胞数量减少。我们的结果表明,从 COPD 发展开始,SOCS 和 STAT 蛋白介导的抗炎反应就受到了下调。这些结果强调了 Th17/Treg 失衡中细胞内信号的重要性,并确定了未来治疗方法的可能靶点。